CS logo
small CS logo
Tartu University Hospital Clinic of Hematology and Oncology

Tartu, Estonia

About Tartu University Hospital Clinic of Hematology and Oncology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
11
Mast Therapeutics, Inc.
1
NSABP Foundation Inc
1
Total Rows: 3

Clinical Trials at Tartu University Hospital Clinic of Hematology and Oncology


During the past decade, Tartu University Hospital Clinic of Hematology and Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 9 clinical trials were completed, i.e. on average, 450% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000000110011223311Started TrialsCompleted Trails2015201620172018201901234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
2008-02-04
2017-05-02
Completed
228
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
2008-04-01
2014-07-01
Terminated
3,509

Rows per page:

1–13 of 13

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Tartu University Hospital Clinic of Hematology and Oncology" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsHoffmann-La Roche: 11Hoffmann-La Roche: 11Mast Therapeutics, Inc.: 1Mast Therapeutics, Inc.: 1NSABP Foundation Inc: 1NSABP Foundation Inc: 1

Created with Highcharts 11.1.0Top CollaboratorsAbbVie: 1AbbVie: 1Cancer InternationalResearch Group (CIRG):1Cancer InternationalResearch Group (CIRG):1Genentech, Inc.: 1Genentech, Inc.: 1German CLL Study Group: 1German CLL Study Group: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1

Clinical Trials Conditions at Tartu University Hospital Clinic of Hematology and Oncology


According to Clinical.Site data, the most researched conditions in "Tartu University Hospital Clinic of Hematology and Oncology" are "Breast Cancer" (3 trials), "Advanced Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Glioblastoma" (1 trials). Many other conditions were trialed in "Tartu University Hospital Clinic of Hematology and Oncology" in a lesser frequency.

Clinical Trials Intervention Types at Tartu University Hospital Clinic of Hematology and Oncology


Most popular intervention types in "Tartu University Hospital Clinic of Hematology and Oncology" are "Drug" (13 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (3 trials), "Docetaxel" (3 trials), "Placebo" (3 trials), "Trastuzumab" (3 trials) and "5-Fluorouracil" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Tartu University Hospital Clinic of Hematology and Oncology


The vast majority of trials in "Tartu University Hospital Clinic of Hematology and Oncology" are 10 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at Tartu University Hospital Clinic of Hematology and Oncology


Currently, there are NaN active trials in "Tartu University Hospital Clinic of Hematology and Oncology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Tartu University Hospital Clinic of Hematology and Oncology, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Tartu University Hospital Clinic of Hematology and Oncology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 10Phase 3: 10Phase 1: 1Phase 1: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 10Completed: 10Active, not recruiting: 1Active, not recruiting: 1Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1